Acta Obstet Gynecol Scand

1. MUNTINGA CLP, Schellekens HCJ, Penders CGJ, van Meir H, et al
   Improving imiquimod use in cervical high-grade squamous intraepithelial lesions: A qualitative study.
   Acta Obstet Gynecol Scand. 2025;104:1712-1719.
   

   >> Share

   
   

   
   Afr J Reprod Health

2. SOHAIL SK
   Pregnancy health literacy and willingness for HPV Testing among pregnant women in Lahore, Pakistan.
   Afr J Reprod Health. 2025;29.
   

   >> Share

   
   

   
   Anticancer Res

3. PARK SJ, Koh JW, Lee TB, Han SI, et al
   Biological Role of Replication Factor C Subunit 4 in Cervical Cancer Cell Progression.
   Anticancer Res. 2025;45:3701-3710.
   

   >> Share

   
   

   
   Appl Radiat Isot

4. LIU T, Wen S, Wang S, Liang R, et al
   Deep learning-based automatic dose optimization for brachytherapy.
   Appl Radiat Isot. 2025;225:111988.
   

   >> Share

   
   

   
   Biochim Biophys Acta Rev Cancer

5. LI X, Zheng J, Liu C, Liu B, et al
   Multidimensional technological advances in cervical cancer screening: From standardized processes to precision medicine.
   Biochim Biophys Acta Rev Cancer. 2025;1880:189432.
   

   >> Share

   
   

   
   Biomedicines

6. MOCANU A, Ujica MA, Horovitz O, Tomoaia G, et al
   Enhanced Stability of Multi-Functionalized Gold Nanoparticles and Potential Anticancer Efficacy on Human Cervical Cancer Cells.
   Biomedicines. 2025;13:1861.
   

   >> Share

   
   
7. HUANG S, Yang R, Yang L, Kong S, et al
   Early Non-Response to Neoadjuvant Chemotherapy Will Increase the Recurrence of Cervical Cancer: A Systematic Review.
   Biomedicines. 2025;13:2016.
   

   >> Share

   
   

   
   BMC Cancer

8. LIM MSH, Tan SSN, Wan Maharuddin IB, Voon PJ, et al
   Survival rates of cervical cancer patients in Sarawak: a single-centre referral study.
   BMC Cancer. 2025;25:1381.
   

   >> Share

   
   

   
   BMC Womens Health

9. GARDNER JE, Jung K, Pluot M, Sherertz T, et al
   Human papillomavirus infection among patients with cervical cancer in Cambodia.
   BMC Womens Health. 2025;25:413.
   

   >> Share

   
   

   
   BMJ Case Rep

10. ORIPOVA M, Abduvaliyeva MM
    Cervical teratoblastoma in a paediatric patient: clinical presentation and management.
    BMJ Case Rep. 2025;18:e265218.
    

    >> Share

    
    

    
    BMJ Glob Health

11. NDEKE JM, Rosenberg M, Yeates KE, Landsittel D, et al
    The relationship between rural residence and cervical cancer screening in three sub-Saharan countries with different national screening policies.
    BMJ Glob Health. 2025;10:e018634.
    

    >> Share

    
    

    
    Cad Saude Publica

12. RIBEIRO CM, Claro IB, Tomazelli JG, Dias MBK, et al
    [Cervical cancer screening in Brazil: a coverage analysis using the Brazilian Cancer Information System].
    Cad Saude Publica. 2025;41:e00152224.
    

    >> Share

    
    

    
    Can Oncol Nurs J

13. LAMANNA A, Gosselin S, Buick C
    Exploring the role of the oncology nurse in cervical cancer screening programs during times of transition.
    Can Oncol Nurs J. 2025;35:223-243.
    

    >> Share

    
    
14. HYMAN J, Slatnik C, Ellwood M
    Cervical cancer treatment and nursing considerations: Best practices for effective care.
    Can Oncol Nurs J. 2025;35:244-263.
    

    >> Share

    
    

    
    Cancer Causes Control

15. OKO-OBOH GA, Auvinen A, Obaseki DE, Pitkaniemi J, et al
    Method of detection, determinants and subsequent treatments for breast, cervical and prostate cancers in Edo-Benin, Nigeria.
    Cancer Causes Control. 2025;36:947-956.
    

    >> Share

    
    
16. LUIZAGA CTM, Camara AB, Cury LCPB, Lopez RVM, et al
    Barriers and attitudes toward cervical cancer screening among eligible women.
    Cancer Causes Control. 2025 Aug 27. doi: 10.1007/s10552-025-02058.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

17. HIGASHI RT, Quirk L, Kruse G, Chen PM, et al
    Process mapping to compare and improve management of abnormal cervical cancer screening results in two U.S. healthcare systems within the PROSPR Consortium.
    Cancer Epidemiol Biomarkers Prev. 2025.
    

    >> Share

    
    

    
    Cancer Prev Res (Phila)

18. ELI AV, Kasten BB, Mayer CM, Samant R, et al
    Contemporary Status and Frontiers of Cervical Cancer Screening in the United States.
    Cancer Prev Res (Phila). 2025 Aug 29. doi: 10.1158/1940-6207.CAPR-25-0118.
    

    >> Share

    
    
19. MOHAMMED E, Taye G, Assefa M, Addissie A, et al
    Effect of health education on cervical cancer screening uptake and knowledge among target women in Addis Ababa: A randomized controlled trial.
    Cancer Prev Res (Phila). 2025 Aug 29. doi: 10.1158/1940-6207.CAPR-25-0188.
    

    >> Share

    
    

    
    Cancer Rep (Hoboken)

20. LI L, Wu H, Chen Y, Shen Z, et al
    Influence of Pre-Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross-Sectional Study.
    Cancer Rep (Hoboken). 2025;8:e70294.
    

    >> Share

    
    
21. LEHTINEN T, Zhang L, Sundquist K, Sundquist J, et al
    Elevated Risk of HPV-Associated Oropharyngeal Cancers in Husbands of Women With Anogenital Cancer.
    Cancer Rep (Hoboken). 2025;8:e70333.
    

    >> Share

    
    

    
    Cureus

22. MISHRA E, Chaudhary E, Mishra S, Rawat V, et al
    Cervical Cancer Screening Using Papanicolaou Smear and Visual Inspection With Acetic Acid and Their Correlation With Colposcopy.
    Cureus. 2025;17:e88679.
    

    >> Share

    
    

    
    Curr Oncol

23. ROBERGE-MALTAIS E, Levesque E, Castonguay V, Marcoux N, et al
    Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report.
    Curr Oncol. 2025;32:469.
    

    >> Share

    
    

    
    Diagnostics (Basel)

24. SAVELIEV GM, Ciuvica AI, Cretoiu D, Varlas VN, et al
    Screening for Cervical Cancer and Early Treatment (SCCET) Project-The Programmatic Data of Romanian Experience in Primary Screening for High-Risk HPV DNA.
    Diagnostics (Basel). 2025;15:2066.
    

    >> Share

    
    

    
    Discov Oncol

25. XU C, Xu Y, Wang G
    Bibliometric analysis of research on cervical cancer and miRNAs from 2010 to 2024: research trends, hotspots, and prospects.
    Discov Oncol. 2025;16:1639.
    

    >> Share

    
    

    
    Elife

26. LIU H, Yu L, Majerciak V, Meyer TJ, et al
    The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells.
    Elife. 2025;13:RP102681.
    

    >> Share

    
    

    
    Eur J Cancer

27. HARDIE AN, Wenzel HHB, Schnack TH, Van der Aa MA, et al
    Response to Letter Re: Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2- a multinational population-based cohort study.
    Eur J Cancer. 2025;228:115743.
    

    >> Share

    
    

    
    Front Oncol

28. GAO F, Shi H, Wang H, Wang J, et al
    Extracellular matrix-related genes-based prognostic signature for cervical cancer: association of LAMA4 expression with prognosis and response to immunotherapy.
    Front Oncol. 2025;15:1562115.
    

    >> Share

    
    

    
    Hum Cell

29. LUNDGREN JG, Flynn MG, List K
    The cell-surface serine protease prostasin is lost during cervical squamous cell carcinogenesis.
    Hum Cell. 2025;38:147.
    

    >> Share

    
    

    
    Hum Vaccin Immunother

30. TORRISI M, Casigliani V, Mammolenti E, Porretta A, et al
    Inequalities in HPV vaccine offer among Italian regions: Analysis of regional prevention plans.
    Hum Vaccin Immunother. 2025;21:2546196.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

31. MARTINS JC, Gouveia MC, Bonadio RC, Scaranti M, et al
    When the blood speaks first: circulating tumor DNA as a biomarker in locally advanced cervical cancer.
    Int J Gynecol Cancer. 2025;35:102020.
    

    >> Share

    
    

    
    Int J Mol Sci

32. SHEN-GUNTHER J, Xia Q, Cai H, Wang Y, et al
    Cervicovaginal Microbiome and HPV: A Standardized Approach to 16S/ITS NGS and Microbial Community Profiling for Viral Association.
    Int J Mol Sci. 2025;26:8090.
    

    >> Share

    
    
33. SEINO R, Fukunaga H
    Deep Learning-Based Imaging Analysis Reveals Radiation-Induced Bystander Effects on Cancer Cell Migration and the Modulation by Cisplatin.
    Int J Mol Sci. 2025;26:7822.
    

    >> Share

    
    
34. NKWINIKA VV, Amissah KA, Rakgole JN, Khaba MC, et al
    APTIMA mRNA vs. DNA-Based HPV Assays: Analytical Performance Insights from a Resource-Limited South African Setting.
    Int J Mol Sci. 2025;26:7450.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

35. WANG Y, Zhang X, Wang F, Chen W, et al
    Dosimetric and Clinical Effects of Polyethylene Glycol Gel in Radical Concurrent Chemoradiotherapy for Cervical Cancer: A Phase III Prospective Multicenter Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2025 Aug 26:S0360-3016(25)06196.
    

    >> Share

    
    

    
    Int J Womens Health

36. EKINU J, Ayikobua ET, Icodu E, Akurut H, et al
    Factors Associated with Cervical Cancer Screening Uptake Among Women Attending Outpatient Department in a Rural District Hospital in Uganda. A Cross-Sectional Study.
    Int J Womens Health. 2025;17:2603-2611.
    

    >> Share

    
    

    
    Iran J Med Sci

37. ZHANG F, Ma Z, Zhang F, Li Y, et al
    Serous and Exosomal LDH-C4 as a Potential Diagnostic and Prognostic Biomarker of Cervical Carcinoma.
    Iran J Med Sci. 2025;50:539-547.
    

    >> Share

    
    

    
    J Gynecol Oncol

38. ASAI-SATO M, Sakaguchi M, Kanemura S, Morishima T, et al
    Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries.
    J Gynecol Oncol. 2025 Aug 25. doi: 10.3802/jgo.2026.
    

    >> Share

    
    

    
    J Pharm Biomed Anal

39. CHEN Y, Xie J, Xie B, Zhong H, et al
    Integrated proteomic and lipidomic analysis revealed potential plasma biomarkers for cervical cancer.
    J Pharm Biomed Anal. 2025;267:117131.
    

    >> Share

    
    

    
    J Xray Sci Technol

40. DU T, Li C, Grzegozek M, Huang X, et al
    PET/CT radiomics for non-invasive prediction of immunotherapy efficacy in cervical cancer.
    J Xray Sci Technol. 2025 Aug 28:8953996251367203. doi: 10.1177/08953996251367203
    

    >> Share

    
    

    
    JMIR Cancer

41. BITAR H, Alismail S
    Toward an Understanding of the Lack of Transmission of Facts About Human Papillomavirus: Qualitative Case Study.
    JMIR Cancer. 2025;11:e64183.
    

    >> Share

    
    

    
    Lancet Public Health

42. POWELL A, Anderson L, Brotherton JML, Butler T, et al
    Cervical screening approach of self-collection, point-of-care HPV testing, and same-day colposcopy among Aboriginal and Torres Strait Islander women in remote Western Australia (the PREVENT Project): an implementation study.
    Lancet Public Health. 2025;10:e732-e740.
    

    >> Share

    
    

    
    Med J Aust

43. BOOTH K, Bryant J, Chandra S, Davies C, et al
    Advancing equity: the urgent need to include trans and gender diverse people in cervical cancer prevention in Australia.
    Med J Aust. 2025 Aug 29. doi: 10.5694/mja2.70041.
    

    >> Share

    
    

    
    Medicina (Kaunas)

44. LEE SM, Seo H, Kim S, Cho HW, et al
    The Value of the Naples Prognostic Score at Diagnosis as a Predictor of Cervical Cancer Progression.
    Medicina (Kaunas). 2025;61:1381.
    

    >> Share

    
    

    
    Medicine (Baltimore)

45. ZHANG R, Kong J, Li Y, Wang H, et al
    Risk of cervical squamous cell carcinoma associated with a single nucleotide polymorphism in the RAD18 gene in the Chinese population and its significance as a predictive biomarker.
    Medicine (Baltimore). 2025;104:e44017.
    

    >> Share

    
    
46. ZOU J, Xu JY, Hua XP, Cao Z, et al
    Knowledge of cervical cancer prevention and HPV vaccination: A survey among 961 college students in Hangzhou, China.
    Medicine (Baltimore). 2025;104:e44069.
    

    >> Share

    
    

    
    Mol Ther

47. SMALLEY TB, Nicolaci AA, Tran KC, Lokhandwala J, et al
    Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer.
    Mol Ther. 2025 Aug 26:S1525-0016(25)00663-X. doi: 10.1016/j.ymthe.2025.
    

    >> Share

    
    

    
    Pan Afr Med J

48. AMUZIE CI, Bassi AP, Fishman E, Mekonnen D, et al
    Parental acceptance of human papillomavirus vaccine for female adolescents in Abia State, southeastern Nigeria: a pre-implementation study.
    Pan Afr Med J. 2025;51:44.
    

    >> Share

    
    

    
    Pathogens

49. SORBYE S, Falang BM, Antonsen M, Mortensen E, et al
    Genotype-Specific HPV mRNA Triage Improves CIN2+ Detection Efficiency Compared to Cytology: A Population-Based Study of HPV DNA-Positive Women.
    Pathogens. 2025;14:749.
    

    >> Share

    
    

    
    Pharmaceutics

50. GUNASEKARAN P, Shin SC, Hwang YS, Lee J, et al
    N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer.
    Pharmaceutics. 2025;17:1027.
    

    >> Share

    
    

    
    PLoS One

51. KASSA B, Mohammed A, Wassie GT
    Parents' acceptance of human papilloma virus vaccination for their daughters in adet town, North Gojjam zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2025;20:e0330911.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

52. NUOVO GJ, Tili E, Croce CM
    Loss of ICOSL expression in the progression to cervical carcinoma.
    Proc Natl Acad Sci U S A. 2025;122:e2509425122.
    

    >> Share

    
    

    
    Rev Panam Salud Publica

53. FATTORE GL, Araoz Olivos N, Leveau CM, Ballejo C, et al
    [Spatial and spatiotemporal inequalities in premature mortality due to cervical cancer in Argentina (2001-2020)Desigualdades espaciais e espaco-temporais na mortalidade prematura por cancer do colo do utero na Argentina (2001-2020)].
    Rev Panam Salud Publica. 2025;49:e90.
    

    >> Share

    
    

    
    Sci Rep

54. ZHANG F, Chen X, Chu C, Chen M, et al
    FEN1 plays a key role in the transition from HSIL to CSCC.
    Sci Rep. 2025;15:30122.
    

    >> Share

    
    
55. EFFAH K, Tekpor E, Ohene-Bredu Y, Ibrahim S, et al
    Assessing high-risk human papillomavirus-based cervical precancer screening recommendations and implications among women aged 60/65 years and older in Ghana.
    Sci Rep. 2025;15:31723.
    

    >> Share

    
    
56. MEKURIA S, Assiged N, Biazin H, Borgfeldt C, et al
    Assessing the feasibility of HPV screening for cervical cancer in pregnant women in Ethiopia.
    Sci Rep. 2025;15:31771.
    

    >> Share

    
    

    
    Traffic

57. WANG Z, Xiao Y, Chen R, Tang E, et al
    From Mechanisms to Therapy: Exploring the Role of Ferroptosis in Cervical Cancer Transformation and Treatment.
    Traffic. 2025;26.
    

    >> Share

    
    

    
    Transl Oncol

58. RANI H, Ganai SA, Mahadevan V
    Histone Deacetylase Inhibitors orchestrate epigenetic signalling and alter the nucleoporins and nuclear envelope in cervical cancer.
    Transl Oncol. 2025;61:102510.
    

    >> Share

    
    

    
    Vaccine

59. ROUX K, Roux F, Burns S, Guy R, et al
    Effective strategies in human papillomavirus (HPV) vaccination interventions to increase uptake in rural, low socioeconomic, indigenous and migrant populations: A scoping review.
    Vaccine. 2025;61:127359.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share